Aziyo Biologics Ownership

Summary

AZYODelisted Stock

USD 2.44 0.00 0.00%

The market capitalization of Aziyo Biologics is $23.72 Million. The majority of Aziyo Biologics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Aziyo Biologics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Aziyo Biologics. Please pay attention to any change in the institutional holdings of Aziyo Biologics as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Some institutional investors establish a significant position in stocks such as Aziyo Biologics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Aziyo Biologics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Aziyo Stock Ownership Analysis

About 70.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.18. Aziyo Biologics had not issued any dividends in recent years. Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic devicecardiovascular, orthopedicspinal repair, and soft tissue reconstruction markets. The company was incorporated in 2015 and is headquartered in Silver Spring, Maryland. Aziyo Biologics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 162 people. For more info on Aziyo Biologics please contact the company at 240 247 1170 or go to https://www.aziyo.com.

Aziyo Biologics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aziyo Biologics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aziyo Biologics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aziyo Biologics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

		Mills C Randal over a year ago Exercise or conversion by Mills C Randal of 22474 shares of Aziyo BiologicsInc subject to Rule 16b-3
		Highcape Capital Lp over a year ago Acquisition by Highcape Capital Lp of 37500 shares of Aziyo BiologicsInc subject to Rule 16b-3
		Mills C Randal over a year ago Exercise or conversion by Mills C Randal of 44947 shares of Aziyo BiologicsInc subject to Rule 16b-3
		Thomas Englese over a year ago Exercise or conversion by Thomas Englese of 937 shares of Aziyo BiologicsInc subject to Rule 16b-3

Aziyo Biologics Outstanding Bonds

Aziyo Biologics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aziyo Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aziyo bonds can be classified according to their maturity, which is the date when Aziyo Biologics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	Dana 575 percent Corp Bond US235822AB96	View
	Volcan Compania Minera Corp Bond USP98047AC08	View
	Boeing Co 2196 Corp Bond US097023DG73	View
	MPLX LP 4875 Corp Bond US55336VAG59	View
	MPLX LP 4125 Corp Bond US55336VAK61	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View

View All Aziyo Biologics Corporate Bonds

Pair Trading with Aziyo Biologics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aziyo Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aziyo Biologics will appreciate offsetting losses from the drop in the long position's value.

Moving against Aziyo Stock

0.68	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.63	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.62	BKRKY	Bank Rakyat	Pair Corr
0.61	PPERY	Bank Mandiri Persero	Pair Corr
0.61	KO	Coca Cola Fiscal Year End 11th of February 2025	Pair Corr

The ability to find closely correlated positions to Aziyo Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aziyo Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aziyo Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aziyo Biologics to buy it.

The correlation of Aziyo Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aziyo Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aziyo Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aziyo Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.

	Commodity Directory Find actively traded commodities issued by global exchanges
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC